Get started
Author

Henrik Depenbrock

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
2015 · Nick Thatcher, Fred R Hirsch, et al. · The Lancet Oncology · 484
Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin
1999 · R. Thödtmann, H. Depenbrock, et al. · Journal of Clinical Oncology · 150
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
2015 · Luis Paz-Ares, Jörg Mezger, et al. · The Lancet Oncology · 135
In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells
1998 · H Depenbrock, R Peter, et al. · British Journal of Cancer · 85
PDF
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
2007 · S. Boeck, K. Weigang-Köhler, et al. · Annals of Oncology · 68
PDF
Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells
1997 · H. Depenbrock, S. Schmelcher, et al. · European Journal of Cancer · 55
Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents
1993 · M Vogel, S.G Hilsenbeck, et al. · European Journal of Cancer · 46
A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC).
2014 · Nick Thatcher, Fred R. Hirsch, et al. · Journal of Clinical Oncology · 41
Effects of cytokines on in vitro colony formation of primary human tumour specimens
1990 · M. Joraschkewitz, H. Depenbrock, et al. · European Journal of Cancer and Clinical Oncology · 35
Gemcitabine and etoposide in small cell lung cancer: phase I and II trials.
1997 · I Rassmann, R Thödtmann, et al. · PubMed · 32
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
2017 · Tudor Ciuleanu, Mark A. Socinski, et al. · Clinical Lung Cancer · 24
Preliminary results of a phase I study with MTA (LY231514) in combination with cisplatin in patients with solid tumors.
1999 · R Thödtmann, H Depenbrock, et al. · PubMed · 21
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
2017 · David R. Spigel, Alexander Luft, et al. · Clinical Lung Cancer · 19
In vitro activity of liposomal N4octadecyl-1-β-D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1-β-D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells
2001 · R.A. Schwendener, K. Friedl, et al. · Investigational New Drugs · 16
Interleukin 1 modulates growth of human renal carcinoma cells in vitro
1995 · I Koch, H Depenbrock, et al. · British Journal of Cancer · 16
PDF
Effects of the microtubule-disturbing agents docetaxel (taxotere®), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro
1994 · A.-R. Hanauske, H. Depenbrock, et al. · European Journal of Cancer · 16
Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)
2016 · Martin Reck, Michael Thomas, et al. · Oncology Research and Treatment · 13
PDF
Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro
1995 · A.-R. Hanauske, K.C. Wüster, et al. · European Journal of Cancer · 13
Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell linesin vitro
1995 · H. Depenbrock, A. Shirvani, et al. · Investigational New Drugs · 12
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
2017 · Keunchil Park, Eun Kyung Cho, et al. · Cancer Research and Treatment · 10
PDF
A phase I study of MTA (multi-targeted antifolate, LY231514) plus cisplatin (CIS) in patients with advanced solid tumours
1997 · R. Thoedtmann, M. Kemmerich, et al. · European Journal of Cancer · 9
Preclinical activity of 17β-[N-[N′-(2-chloroethyl)-N′-nitrosocarbamoyl]-l-alanyl]-5α-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cells
1999 · P Rank, R Peter, et al. · European Journal of Cancer · 8
Dose Intensity Phase l/lI Trial with Carboplatin, Ifosfamide, Etoposide and Vincristine Combined with Filgrastim in Patients with Small-Cell Lung Cancer
2009 · Axel-R. Hanauske, Agnieszka Korfel, et al. · Oncology · 5
Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors
2004 · C. Bolling, C. Lubbing, et al. · Journal of Clinical Oncology · 4
Characterization and mutual ligand-induced modulation of epidermal growth factor and interferon-α receptors on renal carcinoma cells in vitro
1995 · Heike Heise, Henrik Depenbrock, et al. · Anti-Cancer Drugs · 4
Works count: 57
Citation count: 1,340
H-index: 16
I10-index: 20
Year
Topic
Type